← Back to patent-cliff list

Voxvoganan

Tier C — Watch / trade

Voxvoganan

Lytix Biopharma As
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:Updating

Brand:Lytixar

Indications (approved):Staphylococcal infection, COVID-19, Hidradenitis suppurativa, 脓疱病, Gram-positive bacterial infection, Atopic dermatitis

Regional status

US
-
EU
Phase II
2010-09-01
China
-
Japan
-

Synthetic routes & intermediates1 routes

Originator routes × 0Optimised (non-patent) × 1Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OptimisedRoute 1Steps 6 · Total yield /
LTX-109-00113726-76-6LTX-109-00264-04-0LTX-109-003—LTX-109-00437574-71-3LTX-109-00578654-82-7LTX-109-006—LTX-109-0071282610-47-2LTX-109-00813726-76-6LTX-109-009—API · Voxvoganan
CodeCAS No.Intermediate
LTX-109-00113726-76-6(tert-butoxycarbonyl)-L-arginine
LTX-109-00264-04-02-phenylethan-1-amine
LTX-109-003-tert-butyl (S)-(5-guanidino-1-oxo-1-(phenethylamino)pentan-2-yl)carbamate
LTX-109-00437574-71-3(S)-2-amino-5-guanidino-N-phenethylpentanamide
LTX-109-00578654-82-7(S)-2-((tert-butoxycarbonyl)amino)-3-(2,5,7-tri-tert-butyl-1H-indol-3-yl)propanoic acid
LTX-109-006-tert-butyl ((S)-1-(((S)-5-guanidino-1-oxo-1-(phenethylamino)pentan-2-yl)amino)-1-oxo-3-(2,5,7-tri-tert-butyl-1H-indol-3-yl)propan-2-yl)carbamate
LTX-109-0071282610-47-2(S)-2-((S)-2-amino-3-(2,5,7-tri-tert-butyl-1H-indol-3-yl)propanamido)-5-guanidino-N-phenethylpentanamide
LTX-109-00813726-76-6(tert-butoxycarbonyl)-L-arginine
LTX-109-009-tert-butyl ((6S,9S,12S)-1,17-diamino-1,17-diimino-8,11-dioxo-6-(phenethylcarbamoyl)-9-((2,5,7-tri-tert-butyl-1H-indol-3-yl)methyl)-2,7,10,16-tetraazaheptadecan-12-yl)carbamate

Frequently asked questions

What are the approved indications of Voxvoganan?

Approved indications include: Staphylococcal infection, COVID-19, Hidradenitis suppurativa, 脓疱病, Gram-positive bacterial infection, Atopic dermatitis.

When does the Voxvoganan patent expire?

No public expiry year is available for Voxvoganan yet; this page updates once verified.

How many synthesis routes are recorded for Voxvoganan?

1 synthesis routes are recorded; the shortest is 6 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Voxvoganan intermediates?

All intermediates in Voxvoganan routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Voxvoganan intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-21